Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors

NCT02691780 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped not enrolled

Conditions

Interventions

Sponsor

Samsung Medical Center